Sunday, 2 September 2018

Sanofi wins European approval for rare blood-clotting disorder treatment

French drugmaker Sanofi on Monday said it had secured approval in Europe for a rare blood-clotting disorder treatment using nanobodies.


No comments:

Post a Comment